Kolltan Pharmaceuticals Inc.

300 George Street
Suite 530
New Haven
United States

Tel: 203-773-3000
Fax: 203-773-1300

Email: info@kolltan.com

Show jobs for this employer

About Kolltan Pharmaceuticals Inc.

Kolltan, a privately held clinical-stage company, is focused on advancing a new generation of therapeutics in oncology and other diseases by discovering and developing novel biologic agents designed to modulate the function of receptor tyrosine kinases (RTKs). Kolltan is led by an experienced team of executives and scientists with a deep understanding of RTKs, their ligands, and cellular signaling. Located adjacent to the Yale Medical School in New Haven, Connecticut, Kolltan is working in close collaboration with the laboratory of Kolltan co-founder, Dr. Joseph Schlessinger, as well as the Yale medical and scientific community to bring important medicines to cancer patients and other patients with serious diseases. The Company's R&D pipeline is advancing rapidly, with the first clinical trial initiated in January 2014.

41 articles with Kolltan Pharmaceuticals Inc.